QA: Tonix Pharmaceuticals Holding Corp in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001430306_2019_Tonix_Pharmaceuticals_Holding_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp

  xvar xval
0 AssetsCurrent 26,056,000
1 IntangibleAssetsNetIncludingGoodwill 120,000
2 PropertyPlantAndEquipmentNet 43,000
3 remainder_Assets 100,000
4 LiabilitiesCurrent 2,655,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,154,981
9 ResearchAndDevelopmentExpense 19,259,421
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 486,642
13 remainder_ComprehensiveNetIncome -20,567
  yvar yval
0 Assets 26,319,000
1 Liabilities 2,655,000
2 Expenses 28,414,402
3 Revenues 0
4 StockholdersEquity 23,664,000
5 NetIncome -27,927,760
6 ComprehensiveNetIncome -27,938,044
7 BaseVar 28,947,806
8 EconomicCapitalRatiobeforeLimitedLiability 1.63
9 EconomicCapitalRatio 2.77

Edgar->Model Mapping

Feature Distribution

Change over Time